TheKicksShrink

TheKicksShrink Podcast

TheKicksShrink

  • Minisode 58: Why Ozempic Is Psychiatry's SECRET Weapon!

Minisode 58: Why Ozempic Is Psychiatry's SECRET Weapon!

Wednesday 8th November 2023

Join Dr. Mirza as he explores how diabetes meds like Ozempic are transforming mental health care, from weight management to substance use disorder treatment.
Explicit
9 minutes
Informative
Empowering
Hopeful
Educational
Supportive

About this podcast

TheKicksShrink Podcast
Author:
TheKicksShrink
Overview:
Categories:
Sobriety Toolkit
Innovative Treatments & Recovery Paths
Recovery from Trauma
Mindfulness & Technology in Health
Sexual Stigmas & Myths
Links:
Visit site
Rounded Button Dark
Do you want to link to this podcast?
Get the buttons here!

Ozempic's Unexpected Role in Mental Health: A Deep Dive with Dr. Mirza

Episode Overview

  • GLP-1 agonists present a potential solution for weight gain associated with psychiatric medications
  • These medications show promise in reducing cravings for substance use disorders
  • Careful considerations and responsible approaches are essential in their use
  • The episode provides valuable insights into a promising new avenue for interventions in psychiatric care
I've seen it firsthand. Patients who have prescribed it to have gotten a better grasp on their health, both physically and mentally, with them saying that for the first time, that that internal food chatter was finally silenced. That they understood portion control for the first time in their lives, and could finally say, I'm full and I don't need to eat anymore.
What if a diabetes medication could revolutionize mental health treatment? In this episode, Dr. Sulman Aziz Mirza, a triple board-certified psychiatrist, explores how Semaglutide (Ozempic/Wegovy) and Tirzepatide (Mounjaro) are breaking new ground in psychiatry. Originally used for diabetes, these medications are now showing promise in addressing weight gain linked to psychiatric drugs and even helping those battling substance use disorders. Dr.
Mirza brings his expertise to the table, discussing the science behind GLP-1 agonists and GIP analogues, their benefits, and the potential downsides. He doesn't shy away from the complexities, offering a balanced view that includes both hope and caution. This episode is perfect for anyone curious about innovative treatments in mental health or looking for new avenues to explore in their own or a loved one's recovery journey. With a blend of humor and expert insight, Dr.
Mirza makes this complex topic accessible and engaging.
alcoholfree.com
Published by The Mindful Drinking Company Limited
4 Providence Court, Pynes Hill, Exeter, Devon, EX2 5JL, England
Registered in England and Wales.
Company Number: 1195057. Vat Number: GB320915135.
Registered address as above.
© Copyright 2005-2025 The Mindful Drinking Company Limited.
All Rights Reserved.
alcoholfree.com is a participant in the Amazon Associates Programme, an affiliate advertising programme designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.co.uk. As an Amazon Associate, we earn from qualifying purchases.